[1] 任肖敏, 张连营, 郭良宏. 多溴联苯醚和全氟烷基酸的分子毒理机制研究[J]. 环境化学, 2014, 33(10):1662-1671. [2] ZHANG H, YOLTON K, WEBSTER G M, et al. Prenatal PBDE and PCB exposures and reading, cognition, and externalizing behavior in children[J]. Environ Health Perspect, 2017, 125(4):746-752. [3] WOODS C G, HEUVEL J P, RUSYN I. Genomic profiling in nuclear receptor-mediated toxicity[J]. Toxicol Pathol, 2007, 35(4):474-494. [4] MSAAKI W, HIROKI K. Retinoid X receptor antagonists[J]. Int J Mol Sci, 2018, 19(8):23-54. [5] 李云秀, 蒋友胜, 张建清, 等. 2, 2', 4, 4'-四溴联苯醚通过核受体介导神经毒性作用机制的初步研究[J]. 癌变·畸变·突变, 2017, 29(3):172-178. [6] 李振伟, 刘畅, 李春娜, 等. BDE47对Neuro-2a细胞毒性效应及作用机制[J]. 生态毒理学报, 2016, 11(3):145-150. [7] MAKEY C M, MCCLEAN M D, BRAVERMAN L E, et al. Polybrominated diphenyl ether exposure and thyroid function tests in north American adults[J]. Environ Health Perspect, 2016, 124(4):420-425. [8] TANG S Y, LIU H, YIN H, et al. Effect of 2, 2', 4, 4'-tetrabromodiphenyl ether (BDE-47) and its metabolites on cell viability, oxidative stress, and apoptosis of HepG2[J]. Chemosphere, 2018, 193:978-988. [9] WEI J, XIANG L, YUAN Z, et al. Metabolic profiling on the effect of 2, 2', 4, 4'-tetrabromodiphenyl ether (BDE-47) in MCF-7 cells[J]. Chemosphere, 2018, 192:297-304. [10] LI P, LIU L M, ZHOU G Y, et al. Perigestational exposure to low doses of PBDE-47 induces excessive ER stress, defective autophagy and the resultant apoptosis contributing to maternal thyroid toxicity[J]. Sci Total Environ, 2018, 645:363-371. [11] WAN Y J, AN D, CAI Y, et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver[J]. Mol Cell Biol, 2000, 20(12):4436-4444. [12] WNUK A, RZEMIENIEC J, LITWA E, et al. The crucial involvement of retinoid X receptors in DDE neurotoxicity[J]. Neurotox Res, 2016, 29(1):155-172. [13] AHUJA H S, SZANTO A, NAGY L, et al. The retinoid X receptor and its ligands:versatile regulators of metabolic function, cell differentiation and cell death[J]. J Biol Regul Homeost Agents, 2003, 17(1):29-45. [14] THOMAS M, SUKHAI M A, KAMEL-REID S. An emerging role for retinoid X receptor α in malignant hematopoiesis[J]. Leuk Res, 2012, 36(9):1075-1081. [15] VAZ B, DE LERA á R. Advances in drug design with RXR modulators[J]. Expert Opin Drug Discov, 2012, 7(11):1003-1016. [16] YAMADA S, KAKUTA H. Retinoid X receptor ligands:a patent review (2007-2013)[J]. Expert Opin Ther Pat, 2014, 24(4):443-452. [17] PéREZ E, BOURGUET W, GRONEMEYER H, et al. Modulation of RXR function through ligand design[J]. Biochim Biophys Acta, 2012, 1821(1):57-69. [18] NUNEZ J, CELI F S, NG L, et al. Multigenic control of thyroid hormone functions in the nervous system[J]. Mol Cell Endocrinol, 2008, 287(1/2):1-12. [19] MORAN C, CHATTERJEE K. Resistance to thyroid hormone due to defective thyroid receptor alpha[J]. Best Pract Res Clin Endocrinol Metab, 2015, 29(4):647-657. [20] PAUL-FRIEDMAN K, MARTIN M, CROFTON K M, et al. Limited chemical structural diversity found to modulate thyroid hormone receptor in the Tox21 chemical library[J]. Environ Health Perspect, 2019, 127(9):97009. [21] LI A C, PALINSKI W. Peroxisome proliferator-activated receptors:how their effects on macrophages can lead to the development of a new drug therapy against atherosclerosis[J]. Annu Rev Pharmacol Toxicol, 2006, 46:1-39. [22] FANAEE-DANESH E, GALI C C, TADIC J, et al. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells[J]. Biochim Biophys Acta, 2019, 1865(9):2224-2245. [23] EDWARDS L, WATT J, WEBSTER T F, et al. Assessment of total, ligand-induced peroxisome proliferator activated receptor γ ligand activity in serum[J]. Environ Health, 2019, 18(1):45. |